Datasheets | MDB Neurosciences

4 min read

Electrophysiology as a Translational Endpoint: Why Nerve Conduction Belongs in More Preclinical Packages

Aug 4, 2026by MD Biosciences

Most preclinical neuroscience programs are still built around two categories of evidence. Behavior tells you what the...

3 min read

Quantitative Histology: What Computational Image Analysis Adds to a Preclinical Package

Jul 28, 2026by MD Biosciences

Histology has always carried a quiet tension. It is the most direct evidence a preclinical study can offer, a look at...

3 min read

The Cuprizone Model: Reading Demyelination and Remyelination Without the Autoimmune Noise

Jul 21, 2026by MD Biosciences

Remyelination has become the most interesting frontier in multiple sclerosis. The approved therapies for relapsing...

3 min read

What AAALAC Accreditation Actually Signals to Partners

Jul 14, 2026by MD Biosciences

AAALAC accreditation carries practical weight in preclinical drug development, and its implications for program quality...

3 min read

BoNT in Postsurgical Pain: Mechanistic and Behavioral Findings from a Porcine SMIR Model

Jul 7, 2026by MD Biosciences

Botulinum toxin type A has been established as a therapeutic agent in spasticity, dystonia, and cosmetic indications...